These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3286051)

  • 1. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression.
    Siris SG; Adan F; Strahan A; Aronson A; Mandeli J; Fasano-Dube B
    Compr Psychiatry; 1989; 30(6):483-8. PubMed ID: 2582754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA
    Arch Gen Psychiatry; 1994 Feb; 51(2):109-15. PubMed ID: 7905256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia.
    Siris S; Pollack S; Bermanzohn P; Stronger R
    Schizophr Res; 2000 Sep; 44(3):187-92. PubMed ID: 10962221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
    Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
    Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
    Siris SG; Rifkin A; Reardon GT; November M
    Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
    Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
    Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
    Siris SG; Aronson A; Sellew AP
    Biol Psychiatry; 1989 Feb; 25(4):485-8. PubMed ID: 2649158
    [No Abstract]   [Full Text] [Related]  

  • 11. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
    Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
    Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
    J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation treatment with adjunctive imipramine in schizophrenia.
    Siris SG; Bermanzohn PC; Mason SE; Shuwall MA; Aseniero MA
    Psychopharmacol Bull; 1992; 28(3):303-7. PubMed ID: 1480734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Cooper TB; Rifkin AE; Brenner R; Lieberman JA
    Am J Psychiatry; 1982 Jan; 139(1):104-6. PubMed ID: 7055248
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted treatment of depression-like symptoms in schizophrenia.
    Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Fasano-Dube B
    Psychopharmacol Bull; 1987; 23(1):85-9. PubMed ID: 3602335
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive imipramine maintenance in post-psychotic depression/negative symptoms.
    Siris SG; Mason SE; Bermanzohn PC; Alvir JM; McCorry TA
    Psychopharmacol Bull; 1990; 26(1):91-4. PubMed ID: 2371372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
    Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
    Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
    Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
    Swett C; Cole JO; Shapiro S; Slone D
    Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression.
    Siris SG; Frechen K; Strahan A; Cutler J; Owen K; Alvir J; McCorry T
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):369-78. PubMed ID: 1907379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.